These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 25331851)
1. Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity. Ozaki T; Sugimoto H; Nakamura M; Hiraoka K; Yoda H; Sang M; Fujiwara K; Nagase H FEBS J; 2015 Jan; 282(1):114-28. PubMed ID: 25331851 [TBL] [Abstract][Full Text] [Related]
2. Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage. Ozaki T; Wu D; Sugimoto H; Nagase H; Nakagawara A Cell Death Dis; 2013 Apr; 4(4):e610. PubMed ID: 23618908 [TBL] [Abstract][Full Text] [Related]
3. p53 inactivation upregulates p73 expression through E2F-1 mediated transcription. Tophkhane C; Yang SH; Jiang Y; Ma Z; Subramaniam D; Anant S; Yogosawa S; Sakai T; Liu WG; Edgerton S; Thor A; Yang X PLoS One; 2012; 7(8):e43564. PubMed ID: 22952705 [TBL] [Abstract][Full Text] [Related]
4. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells. Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793 [TBL] [Abstract][Full Text] [Related]
5. P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cells. Vayssade M; Haddada H; Faridoni-Laurens L; Tourpin S; Valent A; Bénard J; Ahomadegbe JC Int J Cancer; 2005 Oct; 116(6):860-9. PubMed ID: 15849742 [TBL] [Abstract][Full Text] [Related]
6. Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function. Watson IR; Blanch A; Lin DC; Ohh M; Irwin MS J Biol Chem; 2006 Nov; 281(45):34096-103. PubMed ID: 16980297 [TBL] [Abstract][Full Text] [Related]
7. Runt-related transcription factor 1 (RUNX1) stimulates tumor suppressor p53 protein in response to DNA damage through complex formation and acetylation. Wu D; Ozaki T; Yoshihara Y; Kubo N; Nakagawara A J Biol Chem; 2013 Jan; 288(2):1353-64. PubMed ID: 23148227 [TBL] [Abstract][Full Text] [Related]
8. TAp73-mediated the activation of c-Jun N-terminal kinase enhances cellular chemosensitivity to cisplatin in ovarian cancer cells. Zhang P; Liu SS; Ngan HY PLoS One; 2012; 7(8):e42985. PubMed ID: 22900074 [TBL] [Abstract][Full Text] [Related]
9. TAp73 induction by nitric oxide: regulation by checkpoint kinase 1 (CHK1) and protection against apoptosis. Tebbi A; Guittet O; Cottet MH; Vesin MF; Lepoivre M J Biol Chem; 2011 Mar; 286(10):7873-7884. PubMed ID: 21212274 [TBL] [Abstract][Full Text] [Related]
10. PLK2 phosphorylates and inhibits enriched TAp73 in human osteosarcoma cells. Hu ZB; Liao XH; Xu ZY; Yang X; Dong C; Jin AM; Lu H Cancer Med; 2016 Jan; 5(1):74-87. PubMed ID: 26625870 [TBL] [Abstract][Full Text] [Related]
11. JNK-NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress. Kostecka A; Sznarkowska A; Meller K; Acedo P; Shi Y; Mohammad Sakil HA; Kawiak A; Lion M; Królicka A; Wilhelm M; Inga A; Zawacka-Pankau J Cell Death Dis; 2014 Oct; 5(10):e1484. PubMed ID: 25341038 [TBL] [Abstract][Full Text] [Related]
12. Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia. Tonino SH; Mulkens CE; van Laar J; Derks IA; Suo G; Croon-de Boer F; van Oers MH; Eldering E; Wang JY; Kater AP Leuk Lymphoma; 2015; 56(8):2439-47. PubMed ID: 25511680 [TBL] [Abstract][Full Text] [Related]
13. TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity. Chen D; Ming L; Zou F; Peng Y; Van Houten B; Yu J; Zhang L Oncotarget; 2014 Sep; 5(18):8107-22. PubMed ID: 25237903 [TBL] [Abstract][Full Text] [Related]
14. TNF-α promotes c-REL/ΔNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer. Lu H; Yang X; Duggal P; Allen CT; Yan B; Cohen J; Nottingham L; Romano RA; Sinha S; King KE; Weinberg WC; Chen Z; Van Waes C Cancer Res; 2011 Nov; 71(21):6867-77. PubMed ID: 21933882 [TBL] [Abstract][Full Text] [Related]
15. Cross-talks in the p53 family: deltaNp63 is an anti-apoptotic target for deltaNp73alpha and p53 gain-of-function mutants. Lanza M; Marinari B; Papoutsaki M; Giustizieri ML; D'Alessandra Y; Chimenti S; Guerrini L; Costanzo A Cell Cycle; 2006 Sep; 5(17):1996-2004. PubMed ID: 16931914 [TBL] [Abstract][Full Text] [Related]
16. TAp73 and ΔNp73 have opposing roles in 5-aza-2'-deoxycytidine-induced apoptosis in breast cancer cells. Lai J; Yang F; Zhang W; Wang Y; Xu J; Song W; Huang G; Gu J; Guan X Mol Cells; 2014 Aug; 37(8):605-12. PubMed ID: 25134538 [TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase 2 is involved in DNA damage-mediated cell death of human osteosarcoma cells through stimulation of the ATM/p53 pathway. Sun D; Yu M; Li Y; Xing H; Gao Y; Huang Z; Hao W; Lu K; Kong C; Shimozato O; Ozaki T; Zhu Y FEBS Open Bio; 2019 Mar; 9(3):478-489. PubMed ID: 30868056 [TBL] [Abstract][Full Text] [Related]
19. N-(phosphonacetyl)-L-aspartate induces TAp73-dependent apoptosis by modulating multiple Bcl-2 proteins: potential for cancer therapy. Ruhul Amin AR; Thakur VS; Gupta K; Agarwal MK; Wald DN; Shin DM; Agarwal ML Oncogene; 2013 Feb; 32(7):920-9. PubMed ID: 22430213 [TBL] [Abstract][Full Text] [Related]
20. Apoptin induces apoptosis by changing the equilibrium between the stability of TAp73 and ΔNp73 isoforms through ubiquitin ligase PIR2. Taebunpakul P; Sayan BS; Flinterman M; Klanrit P; Gäken J; Odell EW; Melino G; Tavassoli M Apoptosis; 2012 Aug; 17(8):762-76. PubMed ID: 22484480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]